186 related articles for article (PubMed ID: 31702027)
21. Detection of the Cell Cycle-Regulated Negative Feedback Phosphorylation of Mitogen-Activated Protein Kinases in Breast Carcinoma using Nanofluidic Proteomics.
Urasaki Y; Fiscus RR; Le TT
Sci Rep; 2018 Jul; 8(1):9991. PubMed ID: 29968772
[TBL] [Abstract][Full Text] [Related]
22. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
Lee SY; Shin SJ; Kim HS
Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells.
Chai C; Wu H; Wang B; Eisenstat DD; Leng RP
Carcinogenesis; 2018 Sep; 39(9):1185-1196. PubMed ID: 29985991
[TBL] [Abstract][Full Text] [Related]
24. Liraglutide inhibits the proliferation and promotes the apoptosis of MCF-7 human breast cancer cells through downregulation of microRNA-27a expression.
Zhao W; Zhang X; Zhou Z; Sun B; Gu W; Liu J; Zhang H
Mol Med Rep; 2018 Apr; 17(4):5202-5212. PubMed ID: 29393459
[TBL] [Abstract][Full Text] [Related]
25. Elevated Notch-1 expression promotes the lymph node metastasis of gastric cancer and the Notch-1-PTEN-ERK1/2 signalling axis promotes the progression of gastric cancer.
Ma H; Li N; Mo Z
Cytokine; 2022 Nov; 159():156013. PubMed ID: 36067712
[TBL] [Abstract][Full Text] [Related]
26. MAP kinase: it's been longer than fifteen minutes.
Sturgill TW
Biochem Biophys Res Commun; 2008 Jun; 371(1):1-4. PubMed ID: 18406346
[TBL] [Abstract][Full Text] [Related]
27. Silencing of PTEN inhibits the oxidative stress damage and hippocampal cell apoptosis induced by Sevoflurane through activating MEK1/ERK signaling pathway in infant rats.
Liu T; Dong X; Wang B; Zhang S; Bai J; Ma W; Zhao X; Wang X
Cell Cycle; 2020 Mar; 19(6):684-696. PubMed ID: 32089060
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
[TBL] [Abstract][Full Text] [Related]
29. Homoharringtonine could induce quick protein synthesis of PSMD11 through activating MEK1/ERK1/2 signaling pathway in pancreatic cancer cells.
Wang L; Zhao L; Wei G; Saur D; Seidler B; Wang J; Wang C; Qi T
J Cell Biochem; 2018 Aug; 119(8):6644-6656. PubMed ID: 29665121
[TBL] [Abstract][Full Text] [Related]
30. BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation.
Yan Y; Spieker RS; Kim M; Stoeger SM; Cowan KH
Oncogene; 2005 May; 24(20):3285-96. PubMed ID: 15735702
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.
Wang ZX; Lu BB; Wang H; Cheng ZX; Yin YM
Arch Med Res; 2011 May; 42(4):281-90. PubMed ID: 21820606
[TBL] [Abstract][Full Text] [Related]
32. PTEN-mediated ERK1/2 inhibition and paradoxical cellular proliferation following Pnck overexpression.
Deb TB; Barndt RJ; Zuo AH; Sengupta S; Coticchia CM; Johnson MD
Cell Cycle; 2014; 13(6):961-73. PubMed ID: 24552815
[TBL] [Abstract][Full Text] [Related]
33. miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma.
Chen L; Wang Q; Wang GD; Wang HS; Huang Y; Liu XM; Cai XH
FEBS Lett; 2013 May; 587(9):1366-72. PubMed ID: 23507142
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of miR-194-5p inhibits cell proliferation, migration and invasion in breast cancer by regulating the Wnt/β-catenin signaling pathway.
Yang F; Xiao Z; Zhang S
Int J Mol Med; 2018 Dec; 42(6):3355-3363. PubMed ID: 30272253
[TBL] [Abstract][Full Text] [Related]
35. Src tyrosine kinase inhibits apoptosis through the Erk1/2- dependent degradation of the death accelerator Bik.
Lopez J; Hesling C; Prudent J; Popgeorgiev N; Gadet R; Mikaelian I; Rimokh R; Gillet G; Gonzalo P
Cell Death Differ; 2012 Sep; 19(9):1459-69. PubMed ID: 22388352
[TBL] [Abstract][Full Text] [Related]
36. miR-217 inhibits the migration and invasion of HeLa cells through modulating MAPK1.
Zhu L; Yang S; Wang J
Int J Mol Med; 2019 Nov; 44(5):1824-1832. PubMed ID: 31485607
[TBL] [Abstract][Full Text] [Related]
37. miR‑653‑5p suppresses the growth and migration of breast cancer cells by targeting MAPK6.
Zhang M; Wang H; Zhang X; Liu F
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495824
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
[TBL] [Abstract][Full Text] [Related]
39. Apelin-13 induces MCF-7 cell proliferation and invasion via phosphorylation of ERK1/2.
Peng X; Li F; Wang P; Jia S; Sun L; Huo H
Int J Mol Med; 2015 Sep; 36(3):733-8. PubMed ID: 26135903
[TBL] [Abstract][Full Text] [Related]
40. Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple-negative breast cancer through FRA-1 regulation.
Hoang VT; Matossian MD; La J; Hoang K; Ucar DA; Elliott S; Burks HE; Wright TD; Patel S; Bhatt A; Phamduy T; Chrisey D; Buechlein A; Rusch DB; Nephew KP; Anbalagan M; Rowan B; Cavanaugh JE; Flaherty PT; Miele L; Collins-Burow BM; Burow ME
J Cell Biochem; 2021 Aug; 122(8):835-850. PubMed ID: 33876843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
